These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9921378)

  • 1. The situation of hepatosplenic schistosomiasis in Brazil today.
    Andrade ZA
    Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():313-6. PubMed ID: 9921378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity of Schistosomiasis mansoni in the state of Minas Gerais, Brazil.
    Drummond SC; Silva LC; Amaral RS; Sousa-Pereira SR; Antunes CM; Lambertucci JR
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():37-44. PubMed ID: 17308746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity of schistosomiasis mansoni in a low endemic setting in Ouro Preto, Minas Gerais, Brazil.
    Marinho CC; Grobério AC; Silva CTFD; Lima TLF; Santos RCD; Araújo LG; Reis VWD; Machado-Coelho GLL
    Rev Soc Bras Med Trop; 2017; 50(6):805-811. PubMed ID: 29340458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatosplenic schistosomiasis: comparison of sonographic findings in Brazilian and Sudanese patients--correlation of sonographic findings with clinical symptoms.
    Richter J; Zwingenberger K; Ali QM; Lima Wde M; Dacal AR; de Siqueira GV; Doehring-Schwerdtfeger E; Feldmeier H
    Radiology; 1992 Sep; 184(3):711-6. PubMed ID: 1509054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia as a surrogate marker of hepatosplenic schistosomiasis in endemic areas for Schistosomiasis mansoni.
    Drummond SC; Pereira PN; Otoni A; Chaves BA; Antunes CM; Lambertucci JR
    Rev Soc Bras Med Trop; 2014; 47(2):218-22. PubMed ID: 24861297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution and involution of hepatosplenic schistosomiasis.
    Andrade ZA
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():58-75. PubMed ID: 2700593
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiopulmonary manifestations of hepatosplenic schistosomiasis.
    Lapa M; Dias B; Jardim C; Fernandes CJ; Dourado PM; Figueiredo M; Farias A; Tsutsui J; Terra-Filho M; Humbert M; Souza R
    Circulation; 2009 Mar; 119(11):1518-23. PubMed ID: 19273723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatosplenic schistosomiasis in field-based studies: a combined clinical and sonographic definition.
    Lambertucci JR; Cota GF; Pinto-Silva RA; Serufo JC; Gerspacher-Lara R; Costa Drummond S; Antunes CM; Nobre V; Rayes A
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():147-50. PubMed ID: 11586441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatosplenic Schistosomiasis mansoni with praziquantel. Preliminary report on tolerance and efficacy.
    Coutinho A; Domingues AL; Neves J; Almeida ST
    Arzneimittelforschung; 1983; 33(5):787-91. PubMed ID: 6683560
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of consanguinity in hepatosplenic schistosomiasis in some endemic areas.
    Prata A
    Rev Soc Bras Med Trop; 1988; 21(2):45-6. PubMed ID: 3150594
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of schistosomiasis mansoni, of its clinicopathological forms and of the ectopic locations of the parasite in autopsies in Belo Horizonte, Brazil.
    Gonçalves EC; Fonseca AP; Pittella JE
    J Trop Med Hyg; 1995 Oct; 98(5):289-95. PubMed ID: 7563253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and endoscopic aspects of hepatosplenic schistosomiasis in Uganda.
    Ravera M; Reggiori A; Cocozza E; Ciantia F; Riccioni G
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):693-7. PubMed ID: 8853260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of reversion of hepatosplenic schistosomiasis after specific therapy.
    Dietze R; Prata A
    Rev Soc Bras Med Trop; 1986; 19(2):69-73. PubMed ID: 3432626
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced hepatosplenic schistosomiasis with oxamniquine.
    Farid Z; Higashi GI; Bassily S; Trabolsi B; Watten RH
    Trans R Soc Trop Med Hyg; 1980; 74(3):400-1. PubMed ID: 7434435
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical versus ultrasound examination in the evaluation of hepatosplenic schistosomiasis mansoni in endemic areas.
    Marinho CC; Voieta I; Azeredo LM; Nishi MP; Batista TS; Pereira AC; Serufo JC; Queiroz LC; Ruiz-Guevara R; Antunes CM; Prata A; Lambertucci JR
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():317-21. PubMed ID: 17308789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paracetamol in hepatosplenic bilharziasis.
    Khalil N; Bamil I; Ahmed O; Shalaby E
    J Egypt Med Assoc; 1978; 61(5-6):449-56. PubMed ID: 556101
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatosplenic schistosomiasis: a clinical review.
    De Cock KM
    Gut; 1986 Jun; 27(6):734-45. PubMed ID: 3522373
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombocytopenia as a marker of liver steatosis in a low-endemic area for schistosomiasis mansoni.
    Otoni A; Antunes CMF; Tavares FF; Araújo DHQ; Pereira TA; Queiroz LC; Amâncio FF; Lambertucci JR
    Rev Assoc Med Bras (1992); 2017 Jun; 63(6):532-537. PubMed ID: 28876430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic venous shunt and splenic artery aneurysm in hepatosplenic schistosomiasis.
    Lambertucci JR; Voieta I; Andrade LM
    Rev Soc Bras Med Trop; 2010; 43(2):215-6. PubMed ID: 20464159
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of oxamniquine and praziquantel on intrasplenic pressure and portal vein diameter in hepatosplenic schistosomiasis.
    Massoud AM; Ghoneem M; Massoud M
    J Egypt Soc Parasitol; 1986 Dec; 16(2):427-37. PubMed ID: 3782898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.